Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose olanzapine to prevent postoperative nausea and vomiting after gynecologic laparoscopic surgery
TCTR20221027005Phase 4Unknown
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in postoperative nausea and vomiting (PONV), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Status: unknown.
02
Drugs
olanzapine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20221027005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221027005.